U.S. Patent No. 12,329,781 relates to Minovia’s proprietary mitochondrial augmentation technology for the treatment of renal diseases, including renal tubulopathy, kidney insufficiency, and chronic ...

Drinking electrolyte drinks unnecessarily can put extra stress on the kidneys. Too much sodium and potassium may raise the ...

January is the perfect time to reset and nourish your body. Naturya’s superfood products make healthy living simple with ...

Aim for a balanced diet with a variety of foods in order to get enough vitamin E and vitamin K. While sun protection is good, ...

Systemic therapy for sarcoidosis is reserved for organ-threatening disease, and laryngeal involvement necessitates treatment ...

Long COVID affects an estimated 65 million people worldwide and can damage the brain, heart, blood vessels, and immune system ...

An inclusive job fair helps dialysis patients secure employment, highlighting the importance of flexible work arrangements ...

Minovia Therapeutics Ltd. ("Minovia" or the "Company"), a clinical-stage biotechnology company developing novel therapies to treat mitochondrial diseases ...

The high-risk angioplasty was performed at Kokilaben Dhirubhai Ambani Hospital, Navi Mumbai, on a patient diagnosed with severe multi-vessel coronary artery disease and a critically low ejection ...

The funding, part of a new ARPA-H bioprinting initiative, aims to create transplant-ready organs—potentially within ...

Medical science can typically provide a clear explanation of the intricacies of the human body. However, there are times when ...